Page last updated: 2024-09-03

etomoxir and Allergic Encephalomyelitis

etomoxir has been researched along with Allergic Encephalomyelitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bockermann, R; Corthals, A; Issazadeh-Navikas, S; Kwon, TH; Larsen, A; Mørkholt, AS; Nieland, JDV; Nieland, JGK; Nielsen, S; Oklinski, MK1
Gopalasingam, G; Kastaniegaard, K; Larsen, A; Mørkholt, AS; Nieland, JD; Nielsen, S; Niganze, W; Stensballe, A; Trabjerg, MS1

Other Studies

2 other study(ies) available for etomoxir and Allergic Encephalomyelitis

ArticleYear
Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents.
    PloS one, 2020, Volume: 15, Issue:6

    Topics: Animals; Brain; Carnitine O-Palmitoyltransferase; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Epoxy Compounds; Female; Interleukin-17; Interleukin-4; Mice; Mice, Inbred C57BL; Myelin Sheath; Rats; Rats, Inbred Lew

2020
Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β.
    Scientific reports, 2018, 05-04, Volume: 8, Issue:1

    Topics: Animals; Autoantibodies; Autoantigens; Autoimmunity; Brain; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Epoxy Compounds; Female; Immunoprecipitation; Interferon-beta; Multiple Sclerosis; Rats; Severity of Illness Index

2018